Deborah Cohen. Show Affiliations »
Abstract
Entities: Disease Gene
Mesh: See more » Adamantane/adverse effectsAdamantane/analogs & derivativesAdamantane/therapeutic useDiabetes Mellitus/drug therapyDipeptides/adverse effectsDipeptides/therapeutic useGlucagon-Like Peptide 1/adverse effectsGlucagon-Like Peptide 1/therapeutic useHumansHypoglycemic Agents/adverse effectsHypoglycemic Agents/therapeutic useLinagliptinPancreatitis/chemically inducedPurines/adverse effectsPurines/therapeutic usePyrazines/adverse effectsPyrazines/therapeutic useQuinazolines/adverse effectsQuinazolines/therapeutic useSitagliptin PhosphateTriazoles/adverse effectsTriazoles/therapeutic useUnited States
Substances: See more » DipeptidesHypoglycemic AgentsPurinesPyrazinesQuinazolinesTriazolesLinagliptinGlucagon-Like Peptide 1saxagliptinAdamantaneSitagliptin Phosphate
Year: 2013 PMID: 23613543 DOI: 10.1136/bmj.f2607
Source DB: PubMed Journal: BMJ ISSN: 0959-8138